Clinical Trial

Trial Protocol ID USOR 21271_ZN-c3-004 | GOG 3065

Trial Description

A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Adult Women with Recurrent or Persistent Uterine Serous Carcinoma (ZN-c3-004 | GOG 3065)

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Jeanine L Werner, MD

Disease Types

Sponsor

  • GOG Foundation; K-Group Beta, Inc.

ClinicalTrials.gov NCT ID

  • NCT04814108